Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
about
The role of maintenance therapy in acute promyelocytic leukemia in the first complete remissionAcute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsHigh pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureBiology, risk stratification, and therapy of pediatric acute leukemias: an update.Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two casesGlobal characteristics of childhood acute promyelocytic leukemia.Newly diagnosed acute promyelocytic leukemiaAll-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature ReviewRetrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: Comparisons of four treatment regimes.Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic CriteriaHow I treat children and adolescents with acute promyelocytic leukaemia.Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia.Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009.Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.Recent advances in the diagnosis and management of childhood acute promyelocytic leukemiaRetinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).Recent advances in acute promyelocytic leukaemia.Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis.Treatment of acute promyelocytic leukemia with high white cell blood counts.ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia.Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group.Evaluating mortality in intensive care units: contribution of competing risks analyses.Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol.Long term curative effects of sequential therapy with all-trans retinoic acid, arsenious oxide and chemotherapy on patients with acute promyelocytic leukemia.Quantification of PML/RARa transcript after induction predicts outcome in children with acute promyelocytic leukemia.Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.Hearing impairment accompanied with low-tone tinnitus during all trans retinoic acid containing chemotherapy.Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.A Rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with Skin Involvement by Myeloid Sarcoma.
P2860
Q24200224-CE474633-19B4-4E41-8251-75BB81AB2A0FQ27009433-865A434E-3DF2-445B-842C-6FDD1206D9CEQ34091115-ED2C0FBA-54FA-4043-A97C-937C2EDE8E9DQ34764504-DFE6843E-5248-41CA-ADF5-E8566D67738DQ35103848-71E15A43-68CB-4D4B-99A7-02FC89B28FC8Q35231673-59C3008C-844E-47B5-BEDC-761F641AC857Q35640773-0E79A02B-2E67-46AB-BFDC-E23AF6E0A51BQ36021622-DE3E783B-1E94-45CD-B405-0C7A3AF2248EQ36285651-271F1927-189E-4B93-9CB7-0D60D2D5A9EAQ36430103-A93AC812-3A9F-4A00-ABD6-FD9DEA5A93BCQ37267511-7512D65A-011F-4846-AD20-9FA608DDE28DQ37451376-8FEEE48D-9928-4C10-9B79-7D45ADE8E96DQ37485826-02B3FB09-005C-43E6-96C2-248C5F668300Q37590227-81585EB1-FE13-4174-9B2A-6D5C1AB44924Q37712353-97715C5B-10A4-454B-A83C-CA806A405704Q37899041-BDD0E3C8-2B96-441B-96C0-C6D0E07EE5AAQ38039970-E3D85191-D3EA-473A-A053-F5C606A6D1E9Q38055497-D71269BC-546D-4317-BA81-1EBD06DA8EBDQ38428235-21C53404-940A-42F8-B04C-397ED3308BE9Q38556985-6324DD8A-B399-48A7-B27D-5DA870098B50Q38735007-D686ADA3-D241-4EE4-A006-DF8D798F9CF7Q38798789-AC0B8C92-85C4-4DF6-91C8-DF94C1796C7FQ39021954-CB31D853-2206-4A9B-904D-E8EA8171B2CAQ39103005-88802023-504F-44AC-A08A-43E4010DC34DQ40449095-12F04931-EA18-4BCB-A70C-BFB7C93C3781Q40735293-945809C3-6DCE-40B4-A3F8-2CFD905BAAFBQ41818760-01CC6DB1-16AB-4715-98D5-7ACE6A306190Q42284173-CBC80B08-A04D-414B-8791-0DBA8F5451ABQ42714159-F931258F-C8B7-41F0-996B-AE2A35E6E069Q42720643-6CD4FBC9-2A13-4C81-9E64-C62E41C50430Q45163579-800B56A5-FCB9-4A95-AB6B-DF818AFE278BQ46819268-36887A97-468F-4F03-B119-E52B8C5F8B93Q47568416-E5322A52-7A37-49DE-93E6-62F10DAD8B6DQ48109148-A6C6F6A9-96D7-40FD-87C2-3CDD3F4525BEQ48791883-7C113256-9313-4E7C-BB74-ACD9AD7D1E58Q55031586-0536B7B8-AC16-47EB-BDAB-620FB6AF566C
P2860
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Outcome of childhood acute pro ...... etinoic acid and chemotherapy.
@en
Outcome of childhood acute pro ...... etinoic acid and chemotherapy.
@nl
type
label
Outcome of childhood acute pro ...... etinoic acid and chemotherapy.
@en
Outcome of childhood acute pro ...... etinoic acid and chemotherapy.
@nl
prefLabel
Outcome of childhood acute pro ...... etinoic acid and chemotherapy.
@en
Outcome of childhood acute pro ...... etinoic acid and chemotherapy.
@nl
P2093
P50
P356
P1476
Outcome of childhood acute pro ...... retinoic acid and chemotherapy
@en
P2093
Baruchel A
Bordessoule D
Leverger G
P304
P356
10.1200/JCO.2004.09.008
P407
P577
2004-04-01T00:00:00Z